Ireland· IE-PA-PA1986/113/002
Neotigason 25 mg capsules
A acitretin product containing acitretin, registered in Ireland by Teva B.V.. The same ATC class is registered in 17 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Acitretin is registered in 17 of 19 countries.
Countries holding a registration under ATC D05BB02 (acitretin), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 10 of them publish a price we can compare per daily dose
Acitretin · ATC D05BB02
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of acitretin costs, country by country.
Normalised to the WHO defined daily dose (35 mg), the median price runs from $2.08 in Italy to $4.37 in Switzerland — a ×2.1 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Acitretin · price per daily dose (35 mg)
USD · FX 28 Sept 2026
- CH Switzerland$4.37
- IT Italy$2.08
The record
At a glance
HPRA (Ireland)- Active substance
- Acitretin
- Manufacturer
- Teva B.V.
- Country
- Ireland (IE)
- ATC code
- D05BB02
- ATC class
- Acitretin
- Defined daily dose
- 35 mg, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA1986/113/002
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
147 interactions on record for acitretin.
Graded by severity as the source publishes them — 39 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Acitretin · interactions on record
147 records
- 39 severe
- 30 moderate
- 75 info
Most severe, free to view
- EthanolB05XX04severe
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- IsotretinoinD10AD04severe
3 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Acitretin in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesAcitretinAlembic Pharmaceuticals Inc.
- United KingdomAcitretin 25mg capsulesPhoenix Healthcare Distribution Ltd
- SwitzerlandAcicutan
- BelgiumNeotigason 25 mgPI Pharma
- CanadaMINT-ACITRETINMINT PHARMACEUTICALS INC
- FinlandAcitretin OrifarmOrifarm Generics A/S
- NetherlandsAcitretine CF 25 mg, capsulesCentrafarm B.V.
- NorwayAcitretin OrifarmOrifarm Generics A/S
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Austria · Keracutan
- Belgium · Neotigason
- Czechia · Neotigason
- Germany · Acicutan, Neotigason
- Denmark · Acitretin Orifarm, Neotigason
- Estonia · Neotigason
- Spain · Acitretina Ifc, Neotigason
- Finland · Acitretin Orifarm, Neotigason
- France · Soriatane
- United Kingdom (Northern Ireland) · Acitretin Genus Pharmaceuticals, Acitretin Morningside Healthcare
- Croatia · Neotigason
- Hungary · Neotigason
- Iceland · Neotigason
- Italy · Neotigason, Zorias
- Lithuania · Neotigason
- Luxembourg · Neotigason
- Latvia · Neotigason
- Netherlands · Acitretin Aurobindo, Acitretine Cf
- Norway · Acitretin Orifarm, Neotigason
- Poland · Acitren, Neotigason
- Portugal · Neotigason
- Sweden · Acitretin Orifarm, Neotigason
- Slovenia · Neotigason
- Slovakia · Neotigason
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d125f900-7f35-425e-95e9-5949b29d87b2 GET /v1/drugs/d125f900-7f35-425e-95e9-5949b29d87b2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Capsule, hard",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"D05BB",
"D05BB02"
],
"strength": null,
"pa_number": "PA1986/113/002",
"substances": [
"Acitretin"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "16/06/1992",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about acitretin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.